Fatty liver disease Clinical Trials

3 active Clinical Trials

N/ARecruiting

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

The Non-Invasive Biomarkers for Metabolic Liver Disease (NIMBLE) study is a comprehensive, multi-year collaborative effort to standardize, validate and advance the regulatory qualification of blood- and imaging-based biomarkers to diagnose and stage Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH). MASH is characterized by liver inflammation accompanied by simultaneous fat accumulation in the liver.

Metabolic Associated Fatty Liver Disease· Foundation for the National Institutes of Health· Miami, Florida · Columbus, Ohio +2 more· Ages 18–75
Learn more
Phase 2Recruiting

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

This study is a randomized, double-blind, placebo-controlled trial specifically designed to evaluate the preliminary feasibility, initial efficacy and safety of SGLT2 inhibitors for treating NAFLD in adolescents with obesity.

Non-Alcoholic Fatty Liver Disease· Justin Ryder· Chicago, Illinois· Ages 16–20
Learn more